What are naproxcinod drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

naproxcinod drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

naproxcinod

0 marketed 1 in Phase 3

This page covers all naproxcinod drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

Nitronaproxen · Pain
Nitronaproxen is a prodrug that is converted to naproxen, a nonsteroidal anti-inflammatory drug (NSAID), which works by inhibiting the enzyme cyclooxygenase (COX), thereby reducing the production of prostaglandins and relieving pain and inflammation.

Patent intelligence

naproxcinod patent landscape — aggregated cliff calendar, attackable patents, originator estates